AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: medicinal chemistryClear filter
researchGenetic Engineering and Biotechnology News

Why AI Alone Isn’t Enough for Oligonucleotide Discovery

A new analysis argues that oligonucleotide discovery remains too chemically and biologically complex to be solved by AI alone. The piece is a reminder that in some parts of biopharma, computational power still needs to be paired with deep domain knowledge and experimental iteration.

oligonucleotidesAI drug discoveryRNA therapeuticsbiotechnology
research

AI Designs Are Reaching the Lab Bench, Not Just the Leaderboard

Drug-target AI is moving from benchmark competitions into preclinical testing, a sign the field is maturing beyond paper claims. The crucial question now is whether these designs can survive the harsher reality of experimental biology.

Drug Target Review
preclinical testingdrug designAI models
research

AI Model Finds a Novel Antibiotic Compound as Drug Discovery Looks Past Cancer

A new Technology Networks report says an AI model has generated a novel antibiotic compound, adding momentum to efforts to use machine learning against antimicrobial resistance. The result is significant because antibiotics remain one of the hardest, least forgiving areas of medicinal chemistry.

Technology Networks
AI drug discoveryantibioticsantimicrobial resistance
technology

Variational AI updates Enki 4 as competition intensifies in foundation-model drug discovery

Variational AI has released Enki 4, a major update to its foundation model for small-molecule discovery. The launch reflects a fast-moving race to turn foundation models into repeatable productivity engines for medicinal chemistry rather than one-off demo systems.

Business Wire
foundation modelsmall-molecule discoverymedicinal chemistry
technology

Insilico’s 3D Benchmark Warning Shows Drug Discovery AI Is Entering Its Accountability Era

Insilico Medicine says frontier AI models show important limitations on 3D drug discovery benchmarks, adding a note of caution to the sector’s rapid progress narrative. The announcement is notable because it shifts attention from capability marketing toward the harder question of where these models fail in chemically and biologically meaningful tasks.

TipRanks
Insilico Medicinebenchmarking3D drug discovery

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.